Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Barbara Messing is active.

Publication


Featured researches published by Barbara Messing.


Laryngoscope | 2009

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas

Ahmad R. Sedaghat; Zhe Zhang; Shahnaz Begum; Robert Palermo; Simon R. Best; Karen Ulmer; Marshall A. Levine; Eva S. Zinreich; Barbara Messing; Dorothy Gold; Annie A. Wu; Kevin J. Niparko; Jeanne Kowalski; Richard M. Hirata; John R. Saunders; William H. Westra; Sara I. Pai

The human papillomavirus (HPV) has been identified as a causative factor in 20% to 25% of all head and neck squamous cell carcinomas (HNSCC). Ongoing research suggests that the presence of HPV DNA in HNSCC predicts a positive prognosis with respect to disease‐free and overall survival. However, most studies have been limited by the heterogeneity in treatment regimens and/or anatomic subsites of tumor origin. In this study, we correlate clinical outcomes with HPV status for patients with oropharyngeal carcinomas who were uniformly treated with a concurrent chemoradiation treatment protocol.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2011

Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma.

Simon R. Best; Patrick K. Ha; Ray Blanco; John R. Saunders; Eva S. Zinreich; Marshall A. Levine; Sara I. Pai; Melissa Walker; Jaclyn Trachta; Karen Ulmer; Peter Murakami; Richard E. Thompson; Joseph A. Califano; Barbara Messing

The purpose of this study was to elucidate factors associated with pharyngoesophageal strictures after treatment for head and neck squamous cell carcinoma (SCC).


Journal of Laparoendoscopic & Advanced Surgical Techniques | 2013

Transoral Robotic Surgery Experience in 44 Cases

Ray Blanco; Carole Fakhry; Patrick K. Ha; Keri Ryniak; Barbara Messing; Joseph A. Califano; John R. Saunders

OBJECTIVE To report a single institutions experience with transoral robotic surgery (TORS) and its clinical outcomes. This was a retrospective study carried out at a university-affiliated teaching hospital. SUBJECTS AND METHODS Forty-four consecutive TORS patients with benign and malignant diseases were reviewed. Data on demographics, clinical parameters, and diet were collected. Surgical margins, local and regional recurrence, distant metastasis, 2-year disease-free survival rate, and 2-year survival data were reviewed for the malignant cases. RESULTS Nine benign and 35 proven squamous cell carcinoma (SCCA) cases underwent TORS. The set-up time was 17.12 minutes (range, 10-40 minutes), and operative time was 53 minutes (range, 10-300 minutes). Average length of stay was 2.5 days. There were seven (6.8%) grade 3 surgical complications. Surgical infection rate was 2.3%. Benign cases were on a regular diet after TORS. Of the malignant cases, 94% were taking peroral diet immediately after the TORS procedure. There were no intraoperative complications and no 30-day postoperative mortalities. The mean follow-up time was 25.2 months (range, 16-38 months) for malignant disease. The SCCA sites were in the oropharynx (30/35), larynx (2/35), and unknown primary with neck metastasis (3/35). Unknown primary patients were excluded in the surgical margin analyses. Negative margins were achieved in 91% of cases. The local and regional recurrence rates were 6.3% (2/32) and 3.1% (1/32), respectively. Two patients (6.3%) developed distant metastasis. Oropharyngeal SCCA cases were reviewed, of which 23 were human papillomavirus (HPV)/p16 positive and 7 were HPV/p16 negative. The 2-year actual survival for HPV-positive and -negative patients was 96% (22/23) and 86% (6/7), respectively. The 2-year disease-free survival for HPV-positive and -negative cases was 91% (21/23) and 71.4% (5/7), respectively. All malignant cases that underwent TORS received postoperative adjuvant therapy. CONCLUSIONS TORS is a safe procedure with minimal complications and acceptable clinical and functional outcomes.


American Journal of Otolaryngology | 2015

Pharyngocutaneous fistula after total laryngectomy: A single-institution experience, 2001–2012

Eleni M. Benson; Richard M. Hirata; Carol B. Thompson; Patrick K. Ha; Carole Fakhry; John R. Saunders; Joseph A. Califano; Demetri Arnaoutakis; Marshall A. Levine; Mei Tang; Geoffrey Neuner; Barbara Messing; Ray Blanco

PURPOSE The purpose of this study was to determine the incidence of and risk factors for pharyngocutaneous fistula in patients undergoing total laryngectomy at a single institution. MATERIALS AND METHODS The records of 59 patients undergoing primary or salvage total laryngectomy at our institution from 2001 to 2012 were retrospectively reviewed. Data collected included patient, tumor and treatment characteristics, and surgical technique. Risk factors were analyzed for association with pharyngocutaneous fistula formation. RESULTS Twenty patients (34%) developed fistulas. Preoperative tracheostomy (OR 4.1; 95% CI 1.3-13 [p=0.02]) and low postoperative hemoglobin (OR 9.1; 95% CI 1.1-78 [p=0.04]) were associated with fistula development. Regarding surgical technique, primary sutured closure of the total laryngectomy defect had the lowest fistula rate (11%). In comparison, primary stapled closure and pectoralis onlay flap over primary closure had nonsignificantly increased fistula rates (43%, OR 6.0; 95% CI 1.0-37.3 [p=0.06] and 25%, OR 2.7; 95% CI 0.4-23.9 [p=0.38], respectively). Pectoralis flap incorporated into the suture line had a significantly increased fistula rate (50%, OR 7.1; 95% CI 1.4-46 [p=0.02]). After stratification for salvage status, patient comorbidities were associated with fistula in non-salvage cases whereas disease-related characteristics were associated with fistula in salvage cases. Fistula development was associated with increased length of hospital stay (p<0.001) and increased time before oral diet initiation (p<0.001). CONCLUSIONS Pharyngocutaneous fistula is a common complication of total laryngectomy. Preoperative tracheostomy, postoperative hemoglobin, and surgical technique are important in determining the risk of fistula.


International Journal of Otolaryngology | 2012

Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients

David Zaboli; Marietta Tan; Hrishikesh Gogineni; Spencer Lake; Katherine Y. Fan; Marianna Zahurak; Barbara Messing; Karen Ulmer; Eva S. Zinreich; Marshall A. Levine; Mei Tang; Sara I. Pai; Ray Blanco; John R. Saunders; Simon R. Best; Joseph A. Califano; Patrick K. Ha

Objective. We reviewed a cohort of patients with previously untreated locoregional advanced head and neck squamous cell carcinoma (HNSCC) who received a uniform chemoradiotherapy regimen. Methods. Retrospective review was performed of 105 patients with stage III or IV HNSCC treated at Greater Baltimore Medical Center from 2000 to 2007. Radiation included 125 cGy twice daily for a total 70 Gy to the primary site. Chemotherapy consisted of cisplatin (12 mg/m2/h) daily for five days and 5-fluorouracil (600 mg/m2/20 h) daily for five days, given with weeks one and six of radiation. All but seven patients with N2 or greater disease received planned neck dissection after chemoradiotherapy. Primary outcomes were overall survival (OS), locoregional control (LRC), and disease-free survival (DFS). Results. Median followup of surviving patients was 57.6 months. Five-year OS was 60%, LRC was 68%, and DFS was 56%. Predictors of increased mortality included age ≥55, female gender, hypopharyngeal primary, and T3/T4 stage. Twelve patients developed locoregional recurrences, and 16 patients developed distant metastases. Eighteen second primary malignancies were diagnosed in 17 patients. Conclusions. The CRT regimen resulted in favorable outcomes. However, locoregional and distant recurrences cause significant mortality and highlight the need for more effective therapies to prevent and manage these events.


Laryngoscope | 2015

Evaluation of prophylaxis treatment of Candida in alaryngeal patients with tracheoesophageal voice prostheses.

Barbara Messing; Melissa Kim; Richard M. Hirata; Carol B. Thompson; Samantha Gebhart; Elizabeth A. Sugar; John M. Saunders; James J. Sciubba; Joseph A. Califano

The objective of this study was to evaluate the effectiveness of nystatin and Biotène® mouthwash Oral Rinse for controlling Candida in total laryngectomy (TL) patients with a tracheosophageal voice prosthesis (TEP) because Biotène® mouthwash Oral Rinse is a less costly alternative to nystatin and requires less adherence time.


Journal of Laryngology and Otology | 2017

Human papillomavirus tumour status is not associated with a positive depression screen for patients with oropharyngeal cancer

J. R. Qualliotine; Joseph A. Califano; R. J. Li; Diane R. Gold; Barbara Messing; Gregory Lee; Patrick K. Ha; Carole Fakhry

BACKGROUND Several risk factors for depression in patients with oropharyngeal cancer have been determined. However, it is unknown whether human papillomavirus associated oropharyngeal cancer, which has a distinct clinico-demographic profile, modulates this risk. METHODS A retrospective analysis was conducted of patients with oropharyngeal cancer. These patients had completed a 10-item depression screening questionnaire before receiving treatment for their disease from 2011 to 2014. Associations between patient or disease characteristics and depression screening questionnaire results were investigated. RESULTS The study comprised 69 patients, 31 (44.9 per cent) of whom screened positive for depression. There were no significant differences in distributions of clinico-demographic or histopathological characteristics, including human papillomavirus tumour status, by depression screen result. CONCLUSION This population has a high risk for depression, but no obvious risk factors, including human papillomavirus tumour status, were associated with an elevated risk. This inability to risk-stratify patients by clinico-demographic or disease characteristics emphasises the importance of regular depression screening for all patients in this population.


International Journal of Otolaryngology | 2012

Multidisciplinary Service Utilization Pattern by Advanced Head and Neck Cancer Patients: A Single Institution Study

Jacqueline C. Junn; Irene A. Kim; Marianna Zahurak; Marietta Tan; Katherine Y. Fan; Spencer Lake; David Zaboli; Barbara Messing; Karen Ulmer; Karen Harrer; Dorothy Gold; Keri Ryniak; Eva S. Zinreich; Mei Tang; Marshall A. Levine; Ray Blanco; John R. Saunders; Joseph A. Califano; Patrick K. Ha

Purpose. To analyze the patterns and associations of adjunctive service visits by head and neck cancer patients receiving primary, concurrent chemoradiation therapy. Methods. Retrospective chart review of patients receiving adjunctive support during a uniform chemoradiation regimen for stages III-IV head and neck squamous cell carcinoma. Univariate and multivariate models for each outcome were obtained from simple and multivariate linear regression analyses. Results. Fifty-two consecutive patients were assessed. Female gender, single marital status, and nonprivate insurance were factors associated with an increased number of social work visits. In a multivariate analysis, female gender and marital status were related to increased social work services. Female gender and stage IV disease were significant for increased nursing visits. In a multivariate analysis for nursing visits, living greater than 20 miles between home and hospital was a negative predictive factor. Conclusion. Treatment of advanced stage head and neck cancer with concurrent chemoradiation warrants a multidisciplinary approach. Female gender, single marital status, and stage IV disease were correlated with increased utilization of social work and nursing services. Distance over 20 miles from the center was a negative factor. This information may help guide the treatment team to allocate resources for the comprehensive care of patients.


Otolaryngology-Head and Neck Surgery | 2018

Effects of a Comprehensive Performance Improvement Strategy on Postoperative Adverse Events in Head and Neck Surgery

Bharat A. Panuganti; Yuqi Qiu; Barbara Messing; Gregory Lee; Carole Fakhry; Raymond Blanco; Patrick K. Ha; Karen Messer; Joseph A. Califano

Objectives We aimed to demonstrate the efficacy of a multifaceted performance improvement regimen to reduce the incidence of adverse events following a spectrum of head and neck surgical procedures. Methods We conducted a chart review of patients who underwent a head and neck procedure between January 1, 2013, and October 30, 2015, at our institution, including 392 patients (450 procedures) before the quality improvement regimen was implemented (October 1, 2013) and 942 patients (1136 procedures) after implementation. Multivariate statistical models were used to investigate the association of clinical parameters and the intervention with postoperative adverse event rate. Results The incidence of adverse events decreased from 12.9% to 7.2% (95% CI, 2.46%-9.38%) after the intervention. Male sex (adjusted odds ratio [ORadj] = 1.57; 95% CI, 1.06-2.31) and the intervention (ORadj = 0.51; 95% CI, 0.35-0.74) were predictive of overall adverse event incidence by univariate and multivariate analyses. Although patient comorbid status, quantified with the Charlson Comorbidity Index, was not found to affect overall adverse event risk, each 1-point increase in index score was associated with a 17% relative increase (ORadj = 1.17; 95% CI, 1.03-1.33) in the odds of a high-grade adverse event. Discussion Comprehensive performance improvement programs can improve perioperative adverse event risk in head and neck surgery. Patient comorbid status and sex are considerations during assessment of the likelihood of high-grade and overall adverse event risk, respectively. Implications for Practice Given the cost of surgical complications, a comprehensive approach to perioperative risk mitigation is warranted.


Journal of Voice | 2017

Vocal Health Education and Medical Resources for Graduate-Level Vocal Performance Students

Katherine Latham; Barbara Messing; Melissa Bidlack; Samantha Merritt; Xian Zhou; Lee M. Akst

OBJECTIVE/HYPOTHESIS Most agree that education about vocal health and physiology can help singers avoid the development of vocal disorders. However, little is known about how this kind of education is provided to singers as part of their formal training. This study describes the amount of instruction in these topics provided through graduate-level curricula, who provides this instruction, and the kinds of affiliations such graduate singing programs have with medical professionals. STUDY DESIGN This is an online survey of music schools with graduate singing programs. METHODS Survey questions addressed demographics of the programs, general attitudes about vocal health instruction for singers, the amount of vocal health instruction provided and by whom it was taught, perceived barriers to including more vocal health instruction, and any affiliations the voice program might have with medical personnel. RESULTS Eighty-one survey responses were received. Instruction on vocal health was provided in 95% of the schools. In 55% of the schools, none of this instruction was given by a medical professional. Limited time in the curriculum, lack of financial support, and lack of availability of medical professional were the most frequently reported barriers to providing more instruction. When programs offered more hours of instruction, they were more likely to have some of that instruction given by a medical professional (P = 0.008) and to assess the amount of instruction provided positively (P = 0.001). CONCLUSION There are several perceived barriers to incorporating vocal health education into graduate singing programs. Opportunity exists for more collaboration between vocal pedagogues and medical professionals in the education of singers about vocal health.

Collaboration


Dive into the Barbara Messing's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

John R. Saunders

Greater Baltimore Medical Center

View shared research outputs
Top Co-Authors

Avatar

Patrick K. Ha

University of California

View shared research outputs
Top Co-Authors

Avatar

Ray Blanco

Greater Baltimore Medical Center

View shared research outputs
Top Co-Authors

Avatar

Marshall A. Levine

Greater Baltimore Medical Center

View shared research outputs
Top Co-Authors

Avatar

Carole Fakhry

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Karen Ulmer

Greater Baltimore Medical Center

View shared research outputs
Top Co-Authors

Avatar

Eva S. Zinreich

Greater Baltimore Medical Center

View shared research outputs
Top Co-Authors

Avatar

Dorothy Gold

Greater Baltimore Medical Center

View shared research outputs
Top Co-Authors

Avatar

Geoffrey Neuner

Greater Baltimore Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge